T cell-mediated control of Epstein-Barr virus infection in humanized mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 19832115.
- Also identified by DOI 10.1086/644644.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Humanized NOD/Shi-scid/interleukin-2Rgamma(null) (NOG) mice with full T cell development had significantly longer life span after Epstein-Barr virus (EBV) infection, compared with those with minimal T cell development. Removing CD3(+) or CD8(+) T cells from EBV-infected humanized mice by administration of anti-CD3 or anti-CD8 antibodies reduced their life span. CD8(+) T cells obtained from EBV-infected mice suppressed the outgrowth of autologous B cells isolated from uninfected mice and inoculated with EBV in vitro. These results indicate that humanized NOG mice are capable of T cell-mediated control of EBV infection and imply their usefulness as a tool to evaluate immunotherapeutic and prophylactic strategies for EBV infection.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Disease Models, Animal
- Epstein-Barr Virus Infections
- T-Lymphocyte Subsets